Literature DB >> 18403

Effects of trypan blue treatment on the immune responses of mice.

M L Kripke, K C Norbury, E Gruys, J B Hibbs.   

Abstract

It has been reported that trypan blue treatment decreases the nonspecific resistance of mice to transplanted tumors and inhibits the in vitro cytotoxic activity of activated macrophages. We wished to determine whether this effect of trypan blue could be due to a selective inhibition of certain macrophage functions or whether it reflected a broader form of immunosuppression. We therefore tested the effects of trypan blue on a variety of immunological responses. Treatment of mice with trypan blue delayed their rejection of skin allografts and transplants of a highly antigenic syngeneic ultraviolet light-induced tumor. Trypan blue treatment of either donor or recipient decreased the local graft-versus-host reaction. Filtration of lymph node cells from trypan blue-treated donors on a nylon wool column before use in the graft-versus-host assay abrogated the depressive effect of trypan blue. A transient reduction in the blastogenic response of spleen cells to concanavalin A and lipopolysaccharide mitogens was observed after a single injection of trypan blue, but the response of lymph node cells was unaffected. The depressed response of splenic lymphocytes was not entirely reversed by removal of adherent cells. The primary and secondary hemagglutinin responses to sheep erythrocytes were unaffected in trypan blue-treated mice, and the proportion and phagocytic activity of thioglycolate-induced peritoneal macrophages were also unaltered. We conclude that treatment of mice with trypan blue selectively inhibits certain macrophage functions but, at high doses, it can also inhibit some lymphocyte activities.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18403      PMCID: PMC421091          DOI: 10.1128/iai.17.1.121-129.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Phagocytic cells as effectors in a cell-mediated immunity system.

Authors:  G Dennert; E S Lennox
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

2.  Differentiation of immunologically specific cytotoxic macrophages into two types on the basis of radiosensitivity.

Authors:  W Den Otter; R Evans; P Alexander
Journal:  Transplantation       Date:  1974-11       Impact factor: 4.939

Review 3.  The peritoneal cavity as a site for studying cell-cell and cell-virus interactions.

Authors:  J Padawer
Journal:  J Reticuloendothel Soc       Date:  1973-11

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Regulations of lymphocyte responses in vitro. IV. Role of macrophages in rat lymphocyte responses and their inhibition by cytochalasin B.

Authors:  M Yoshinaga; B H Waksman
Journal:  Ann Immunol (Paris)       Date:  1973-02

6.  Inhibition of in vitro immune response by treatment of spleen cell suspensions with anti-theta serum.

Authors:  A Schimpl; E Wecker
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

7.  The macrophage in allograft immunity. II. Passive transfer with immune macrophages.

Authors:  N N Pearsall; R S Weiser
Journal:  J Reticuloendothel Soc       Date:  1968-04

8.  Graft-versus-host reaction in the rat popliteal lymph node.

Authors:  W W Bonney; T L Feldbush
Journal:  Transplantation       Date:  1973-02       Impact factor: 4.939

9.  Popliteal lymph node weight gain assay for graft-versus-host reactivity in mice.

Authors:  V W Twist; R D Barnes
Journal:  Transplantation       Date:  1973-01       Impact factor: 4.939

10.  Infection and transformation of mouse peritoneal macrophages by simian virus 40.

Authors:  J Mauel; V Defendi
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  9 in total

1.  Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.

Authors:  M B McGeorge; P S Morahan
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  Studies on the adjuvant action of beryllium. IV. The preparation of beryllium containing macromolecules that induce immunoblast responses in vivo.

Authors:  J G Hall
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

3.  Suppression of tuberculoimmunity in mice by Evans blue dye.

Authors:  A J Crowle; M H May
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Suramin effects on macrophage phagolysosome formation and antimicrobial activity.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

5.  Systemic candidiasis from Candida albicans colonizing the gastrointestinal tract of mice.

Authors:  T Umenai; S Konno; N Ishida
Journal:  Experientia       Date:  1979-10-15

6.  Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice.

Authors:  D W Anderson; A J Crowle
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Trypan blue inhibition of complement receptor function on various cells.

Authors:  B L Harper; D P Fine; J C Guckian; T Cavallo
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

8.  Complement does not play a role in promoting Babesia rodhaini infections in Balb/C mice.

Authors:  W Seinen; T Stegmann; H Kuil
Journal:  Z Parasitenkd       Date:  1982

9.  Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.

Authors:  R Kearney; R L Wu; F Orr
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.